Akari Targets Mid-2027 for Human Trial of Differentiated Cancer Therapy - Akari Therapeutics (NASDAQ:AKTX
Akari Therapeutics Stock (AKTX) Explodes 242% on Strong Cancer Drug Data and $5.5M Funding Boost - TipRanks.com
Why Vanda Pharmaceuticals Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - Antelope Ent Hldgs (NASDAQ:AEHL), Aimei Health Technology (NASDAQ:AFJK)